Jonathan M. Spergel researcher
Spergel, Jonathan M.
VIAF ID: 171129535 (Personal)
Permalink: http://viaf.org/viaf/171129535
Preferred Forms
- 100 0 _ ‡a Jonathan M. Spergel ‡c researcher
- 200 _ | ‡a Spergel ‡b Jonathan M.
- 100 1 _ ‡a Spergel, Jonathan M.
- 100 1 _ ‡a Spergel, Jonathan M.
- 100 1 _ ‡a Spergel, Jonathan M.
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Atopic dermatitis in childhood and adolescence, c2011: | |
The epidemiologic characteristics of healthcare provider-diagnosed eczema, asthma, allergic rhinitis, and food allergy in children: a retrospective cohort study | |
Epinephrine auto-injector carriage and use practices among US children, adolescents, and adults | |
Esophageal epithelial and mesenchymal cross-talk leads to features of epithelial to mesenchymal transition in vitro. | |
Filaggrin mutations and atopy: consequences for future therapeutics | |
Food allergy and additives: triggers in asthma. | |
Food Allergy in Infants With Atopic Dermatitis: Limitations of Food-Specific IgE Measurements | |
Food allergy. Mechanisms, diagnosis, and management in children. | |
Food allergy presenting as a "septic"-appearing infant | |
Food allergy: review, classification and diagnosis | |
Food allergy to uncommonly challenged foods is rare based on oral food challenge | |
Food protein-induced enterocolitis syndrome: insights from review of a large referral population. | |
From atopic dermatitis to asthma: the atopic march | |
Gene network analysis in a pediatric cohort identifies novel lung function genes | |
The global impact of the DRACMA guidelines cow’s milk allergy clinical practice | |
GWAS identifies four novel eosinophilic esophagitis loci | |
Idiopathic Anaphylaxis and Undiagnosed Anorexia Nervosa | |
IgE blockade during food allergen ingestion enhances the induction of inhibitory IgG antibodies | |
The Illness Management Survey: identifying adolescents' perceptions of barriers to adherence. | |
The Immunologic Mechanisms of Eosinophilic Esophagitis. | |
The importance of reducing risk in peanut allergy: Current and future therapies. | |
The importance of TSLP in allergic disease and its role as a potential therapeutic target | |
Improving allergy office scheduling increases patient follow up and reduces asthma readmission after pediatric asthma hospitalization | |
An in-depth characterization of a large cohort of adult patients with eosinophilic esophagitis | |
Interleukin 6 enhances a cellular activity that functionally substitutes for E1A protein in transactivation | |
International consensus guidelines for the diagnosis and management of food protein-induced enterocolitis syndrome: Executive summary-Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology | |
Invariant natural killer cells change after an oral allergy desensitization protocol for cow's milk. | |
Is It Time for a Randomized Trial on Early Introduction of Milk? | |
Late diagnosis of tree nut and sesame allergy in patients previously sensitized but tolerant to peanut | |
Letter of response to Greenhawt et al. 'LEAPing Through the Looking Glass: Secondary Analysis of the Effect of Skin Test Size and Age of Introduction on Peanut Tolerance after Early Peanut Introduction'. | |
The link between allergies and eosinophilic esophagitis: implications for management strategies | |
Management of difficult-to-treat atopic dermatitis. | |
Microbiome and its impact on gastrointestinal atopy. | |
The natural history of eosinophilic oesophagitis in the transition from childhood to adulthood. | |
Natural history of peanut allergy. | |
New pathways for itching in patients with atopic dermatitis? | |
NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A | |
Nonimmunoglobulin e-mediated immune reactions to foods | |
An obligate role for T-cell receptor alphabeta+ T cells but not T-cell receptor gammadelta+ T cells, B cells, or CD40/CD40L interactions in a mouse model of atopic dermatitis | |
Omalizumab facilitates rapid oral desensitization for peanut allergy. | |
Oral food challenge to wheat: a near-fatal anaphylaxis and review of 93 food challenges in children | |
Oral viscous budesonide can be successfully delivered through a variety of vehicles to treat eosinophilic esophagitis in children. | |
Otolaryngologists may not be doing enough to diagnose pediatric eosinophilic esophagitis | |
Pimecrolimus cream in the management of patients with atopic eczema | |
Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants | |
Prevalence of biphasic response in anaphylaxis due to purposeful administration of allergenic food. | |
The Prevalence of Eosinophilic Esophagitis in Pediatric Patients with IgE-Mediated Food Allergy. | |
Primary prevention of allergic disease through nutritional interventions | |
Proton pump inhibitor-responsive oesophageal eosinophilia: too early to change clinical practice | |
Relating microarray component testing and reported food allergy and food-triggered atopic dermatitis: a real-world analysis | |
Reply to: Medication contaminants as a potential cause of anaphylaxis to vincristine: What about drug specific antigens? | |
Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. | |
Resolution of childhood peanut allergy. | |
Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. | |
Safe administration of the seasonal trivalent influenza vaccine to children with severe egg allergy. | |
Safety of topical calcineurin inhibitors in atopic dermatitis: evaluation of the evidence. | |
Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis | |
Should wheat, barley, rye, and/or gluten be avoided in a 6-food elimination diet? | |
Study of the Atopic March: Development of Atopic Comorbidities | |
Summary of the updated international consensus diagnostic criteria for eosinophilic esophagitis: AGREE conference | |
Sustained milk consumption after 2 years post-Milk Epicutaneous immunotherapy for Eosinophilic Esophagitis | |
Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis | |
Temporal Regulation by Innate Type 2 Cytokines in Food Allergies | |
Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. | |
Thymic stromal lymphopoietin-mediated extramedullary hematopoiesis promotes allergic inflammation. | |
To treat or not to treat: The minimally symptomatic EoE patient | |
Toll-like receptor 2 stimulation augments esophageal barrier integrity | |
Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. | |
Treatment of gastric eosinophilia by epicutaneous immunotherapy in piglets sensitized to peanuts. | |
The urgent need for a harmonized severity scoring system for acute allergic reactions. | |
The use of patch testing in the diagnosis of food allergy. | |
Variants of DENND1B associated with asthma in children | |
Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. |